Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19
Status:
Recruiting
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
This study is a multi-center randomized, controlled, and blinded clinical trial study that
will be performed in four medical-educational centers. In this study, the samples will be
selected from among patients with SARS-CoV-2 as easy access and based on entry criteria and
will be randomly divided into two groups, including a control group and an intervention
group. The study will be conducted in four medical centers. From each center, 56 definitive
Corona patients will be selected, who will be randomly divided into two groups of 28, for a
total of 224 patients will enter the study. In the intervention group, in addition to
receiving the test spray, Patients will also receive standard treatment